Reperfusion Therapies for Acute Ischemic Stroke in COVID-19 Patients: A Nationwide Multi-Center Study

(1) Background: Acute ischemic stroke (AIS) is a possible complication of the coronavirus disease 2019 (COVID-19). Safety and efficacy data on reperfusion therapies (RT)—intravenous thrombolysis and endovascular treatment (EVT)—in stroke patients with COVID-19 is lacking. (2) Methods: We performed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurkevičienė, Justina, Vaišvilas, Mantas, Masiliūnas, Rytis, Matijošaitis, Vaidas, Vaitkus, Antanas, Geštautaitė, Dovilė, Taroza, Saulius, Puzinas, Paulius, Galvanauskaitė, Erika, Jatužis, Dalius, Vilionskis, Aleksandras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181080/
https://www.ncbi.nlm.nih.gov/pubmed/35683393
http://dx.doi.org/10.3390/jcm11113004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181080/
https://www.ncbi.nlm.nih.gov/pubmed/35683393
http://dx.doi.org/10.3390/jcm11113004

Ejemplares similares